Skip to main content
Erschienen in: Journal of Cancer Education 1/2015

01.03.2015

Evaluating a Community-Partnered Cancer Clinical Trials Pilot Intervention with African American Communities

verfasst von: Melissa A. Green, Margo Michaels, Natasha Blakeney, Adebowale A. Odulana, Malika Roman Isler, Alan Richmond, Debra G. Long, William S. Robinson, Yhenneko J. Taylor, Giselle Corbie-Smith

Erschienen in: Journal of Cancer Education | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Cancer clinical trial (CCT) accrual and retention rates remain disproportionately low among African Americans. Awarenesss and access to trials are crucial facilitators of trial participation. Strategies developed within a community-based participatory framework (CBPR) are potential solutions to increase awareness and access to CCTs. In this study, we describe the pilot phase of three innovative community-centered modules to improve basic CCT knowledge, awareness of locations to access CCT information, and opportunities to participate in CCTs. Four community organizations completed Community Bridges to CCT training-of-the-trainer and recruited adult African American volunteers to participate in one of three CCT education modules: a workshop about CCTs, a role play describing one person’s experience with CCTs, or a call and response session reviewing myths and facts about CCTs. Pre- and post-test surveys were collected and analyzed using McNemar agreement statistic to evaluate changes in knowledge and attitudes regarding trials. Trainers enrolled 125 participants in the call and response (n = 22), role play (n = 60), and workshop (n = 43) modules. Module participants were mostly African American, female, and with a mean age of 53 years. Comparison of pre- and post-test responses demonstrates favorable changes in awareness of CCTs and where to access CCTs across the sample. Analysis by module type indicates significant increases for participants in the call and response (p < 0.01) and role play modules (p < 0.001), but not the workshop module. Despite measures taken to increase the participation and retention rate of African Americans in clinical trials, little advancement has been made. Developing tailored community education modules on CCTs within the CBPR framework is a promising innovation to increase knowledge about CCTs and favorable attitudes about participation that are known precursors to trial enrollment.
Literatur
1.
Zurück zum Zitat IOM (Institute of Medicine) (2009) Multi-center Phase III Clinical Trials and NCI Cooperative Groups: workshop summary IOM (Institute of Medicine) (2009) Multi-center Phase III Clinical Trials and NCI Cooperative Groups: workshop summary
2.
Zurück zum Zitat Kwiatkowski K, Coe K, Bailar JC, Marie Swanson G (2013) Inclusion of minorities and women in cancer clinical trials, a decade later: have we improved? Cancer 119:2956–2963CrossRefPubMed Kwiatkowski K, Coe K, Bailar JC, Marie Swanson G (2013) Inclusion of minorities and women in cancer clinical trials, a decade later: have we improved? Cancer 119:2956–2963CrossRefPubMed
3.
Zurück zum Zitat Carpenter WR, Tyree S, Wu Y, Meyer AM, Dimartino L, Zullig L, Godley PA (2012) A surveillance system for monitoring, public reporting, and improving minority access to cancer clinical trials. Clin Trials 9(4):426–435CrossRefPubMedCentralPubMed Carpenter WR, Tyree S, Wu Y, Meyer AM, Dimartino L, Zullig L, Godley PA (2012) A surveillance system for monitoring, public reporting, and improving minority access to cancer clinical trials. Clin Trials 9(4):426–435CrossRefPubMedCentralPubMed
4.
Zurück zum Zitat Ford Jean G, Howerton MW, Lai GY, Gary TL, Shari Bolen M, Chris G, Jon T, Charles B, Teerath Peter T, Wilson RF (2008) Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112(2):228–242CrossRefPubMed Ford Jean G, Howerton MW, Lai GY, Gary TL, Shari Bolen M, Chris G, Jon T, Charles B, Teerath Peter T, Wilson RF (2008) Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112(2):228–242CrossRefPubMed
5.
Zurück zum Zitat Rivers D, August EM, Ivana S, Lee Green B, Quinn GP (2013) A systematic review of the factors influencing African Americans' participation in cancer clinical trials. Contemp Clin Trials 35(2):13–32CrossRefPubMed Rivers D, August EM, Ivana S, Lee Green B, Quinn GP (2013) A systematic review of the factors influencing African Americans' participation in cancer clinical trials. Contemp Clin Trials 35(2):13–32CrossRefPubMed
6.
Zurück zum Zitat Evans Kiameesha R, Jane Lewis M, Hudson SV (2012) The role of health literacy on African American and Hispanic/Latino perspectives on cancer clinical trials. J Cancer Educ 27(2):299–305CrossRefPubMedCentralPubMed Evans Kiameesha R, Jane Lewis M, Hudson SV (2012) The role of health literacy on African American and Hispanic/Latino perspectives on cancer clinical trials. J Cancer Educ 27(2):299–305CrossRefPubMedCentralPubMed
7.
Zurück zum Zitat Bailey Joanne M, Bieniasz ME, David K, Brenner DE, Ruffin MT (2004) Recruitment and retention of economically underserved women to a cervical cancer prevention trial. Appl Nurs Res 17(1):55–60CrossRefPubMed Bailey Joanne M, Bieniasz ME, David K, Brenner DE, Ruffin MT (2004) Recruitment and retention of economically underserved women to a cervical cancer prevention trial. Appl Nurs Res 17(1):55–60CrossRefPubMed
8.
Zurück zum Zitat Bodurtha JN, Quillin JM, Tracy KA, Borzelleca J, McClish D, Wilson DB, Jones RM, Quillin J, Bowen D (2007) Recruiting diverse patients to a breast cancer risk communication trial--waiting rooms can improve access. J Natl Med Assoc 99(8):917–922PubMedCentralPubMed Bodurtha JN, Quillin JM, Tracy KA, Borzelleca J, McClish D, Wilson DB, Jones RM, Quillin J, Bowen D (2007) Recruiting diverse patients to a breast cancer risk communication trial--waiting rooms can improve access. J Natl Med Assoc 99(8):917–922PubMedCentralPubMed
9.
Zurück zum Zitat Champion Victoria L, Springston JK, Zollinger TW, Saywell Jr RM, Monahan PO, Qianqian Z, Russell KM (2006) Comparison of three interventions to increase mammography screening in low income African American women. Cancer Detect Prev 30(6):535–544CrossRefPubMed Champion Victoria L, Springston JK, Zollinger TW, Saywell Jr RM, Monahan PO, Qianqian Z, Russell KM (2006) Comparison of three interventions to increase mammography screening in low income African American women. Cancer Detect Prev 30(6):535–544CrossRefPubMed
10.
Zurück zum Zitat Cook ED, Arnold KB, Hermos JA, McCaskill-Stevens W, Moody-Thomas S, Probstfield JL, Hamilton SJ, Campbell RD, Anderson KB, Minasian LM (2010) Impact of supplemental site grants to increase African American accrual for the Selenium and Vitamin E Cancer Prevention Trial. Clin Trials 7(1):90–99. doi:10.1177/1740774509357227 CrossRefPubMedCentralPubMed Cook ED, Arnold KB, Hermos JA, McCaskill-Stevens W, Moody-Thomas S, Probstfield JL, Hamilton SJ, Campbell RD, Anderson KB, Minasian LM (2010) Impact of supplemental site grants to increase African American accrual for the Selenium and Vitamin E Cancer Prevention Trial. Clin Trials 7(1):90–99. doi:10.​1177/​1740774509357227​ CrossRefPubMedCentralPubMed
11.
Zurück zum Zitat Greenwald P (2004) Clinical trials in cancer prevention: current results and perspectives for the future. J Nutr 134(12):3507S-3512S Greenwald P (2004) Clinical trials in cancer prevention: current results and perspectives for the future. J Nutr 134(12):3507S-3512S
13.
Zurück zum Zitat Pinsky PF, Ford M, Gamito E, Higgins D, Jenkins V, Lamerato L, Tenorio S, Marcus PM, Gohagan JK (2008) Enrollment of racial and ethnic minorities in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. J Natl Med Assoc 100(3):291–298PubMed Pinsky PF, Ford M, Gamito E, Higgins D, Jenkins V, Lamerato L, Tenorio S, Marcus PM, Gohagan JK (2008) Enrollment of racial and ethnic minorities in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. J Natl Med Assoc 100(3):291–298PubMed
14.
Zurück zum Zitat Denicoff AM, McCaskill-Stevens W, Grubbs SS, Bruinooge SS, Comis RL, Devine P, Dilts DM, Duff ME, Ford JG, Joffe S, Schapira L, Weinfurt KP, Michaels M, Raghavan D, Richmond ES, Zon R, Albrecht TL, Bookman MA, Dowlati A, Enos RA, Fouad MN, Good M, Hicks WJ, Loehrer PJ Sr, Lyss AP, Wolff SN, Wujcik DM, Meropol NJ (2013) The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations. J Oncol Pract 9(6):268–276CrossRef Denicoff AM, McCaskill-Stevens W, Grubbs SS, Bruinooge SS, Comis RL, Devine P, Dilts DM, Duff ME, Ford JG, Joffe S, Schapira L, Weinfurt KP, Michaels M, Raghavan D, Richmond ES, Zon R, Albrecht TL, Bookman MA, Dowlati A, Enos RA, Fouad MN, Good M, Hicks WJ, Loehrer PJ Sr, Lyss AP, Wolff SN, Wujcik DM, Meropol NJ (2013) The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations. J Oncol Pract 9(6):268–276CrossRef
15.
Zurück zum Zitat Seifer Sarena D, Margo M, Stacy C (2010) Applying community-based participatory research principles and approaches in clinical trials: forging a new model for cancer clinical research. Prog Commun Health Partnerships: Res Educ Action 4(1):37–46CrossRef Seifer Sarena D, Margo M, Stacy C (2010) Applying community-based participatory research principles and approaches in clinical trials: forging a new model for cancer clinical research. Prog Commun Health Partnerships: Res Educ Action 4(1):37–46CrossRef
16.
Zurück zum Zitat Michaels M, Weiss ES, Guidry JA, Natasha B, Liz S, Brian G, Samantha Y, Bruce R, Robert G, Lisbeth Jarama S (2012) The promise of community-based advocacy and education efforts for increasing cancer clinical trials accrual. J Cancer Educ 27(1):67–74CrossRefPubMed Michaels M, Weiss ES, Guidry JA, Natasha B, Liz S, Brian G, Samantha Y, Bruce R, Robert G, Lisbeth Jarama S (2012) The promise of community-based advocacy and education efforts for increasing cancer clinical trials accrual. J Cancer Educ 27(1):67–74CrossRefPubMed
17.
Zurück zum Zitat Jones L, Kenneth W (2007) Strategies for academic and clinician engagement in community-participatory partnered research. Jama 297(4):407–410CrossRefPubMed Jones L, Kenneth W (2007) Strategies for academic and clinician engagement in community-participatory partnered research. Jama 297(4):407–410CrossRefPubMed
18.
Zurück zum Zitat Viswanathan M, Ammerman A, Eng E, Garlehner G, Lohr KN, Griffith D, Rhodes S, Samuel-Hodge C, Maty S, Lux L, Webb L, Sutton SF, Swinson T, Jackman A and Whitener L (2004) Community-based participatory research: assessing the evidence. Evidence Report/Technology Assessment No. 99 99 Viswanathan M, Ammerman A, Eng E, Garlehner G, Lohr KN, Griffith D, Rhodes S, Samuel-Hodge C, Maty S, Lux L, Webb L, Sutton SF, Swinson T, Jackman A and Whitener L (2004) Community-based participatory research: assessing the evidence. Evidence Report/Technology Assessment No. 99 99
19.
Zurück zum Zitat Blakeney Natasha, Margo Michaels, Melissa Green, Alan Richmond, Debra Long, William S. Robinson, Carmelita Spicer, Sharon Elliott-Bynum and Giselle Corbie-Smith (2014) Collaborative development of clinical trials education programs for African-American community-based organizations. Journal of Cancer Education Blakeney Natasha, Margo Michaels, Melissa Green, Alan Richmond, Debra Long, William S. Robinson, Carmelita Spicer, Sharon Elliott-Bynum and Giselle Corbie-Smith (2014) Collaborative development of clinical trials education programs for African-American community-based organizations. Journal of Cancer Education
20.
Zurück zum Zitat McNemar Q (1947) Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika 12:153–157CrossRefPubMed McNemar Q (1947) Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika 12:153–157CrossRefPubMed
21.
Zurück zum Zitat Sheba G, Moran E, Duran N, Jenders RA (2013) Using animation as an information tool to advance health research literacy among minority participants. AMIA Annu Symp Proc 475–484 Sheba G, Moran E, Duran N, Jenders RA (2013) Using animation as an information tool to advance health research literacy among minority participants. AMIA Annu Symp Proc 475–484
22.
Zurück zum Zitat Ford Jean G, Mollie W. Howerton, Shari Bolen, Tiffany L. Gary, Gabriel Y. Lai, Jon Tilburt, M. Chris Gibbons, Charles Baffi, Renee F. Wilson and Carolyn J. Feuerstein (2005) Knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials. Agency for Healthcare Research and Quality Rockville, MD Ford Jean G, Mollie W. Howerton, Shari Bolen, Tiffany L. Gary, Gabriel Y. Lai, Jon Tilburt, M. Chris Gibbons, Charles Baffi, Renee F. Wilson and Carolyn J. Feuerstein (2005) Knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials. Agency for Healthcare Research and Quality Rockville, MD
24.
Zurück zum Zitat Dignan M, Mary E, Polly K, Lori A, Pollack LA, Maria P, Judith Lee S, Heather P-P, Peter H, Christopher W, Sandral H (2011) Recruitment of low income, predominantly minority cancer survivors to a randomized trial of the I Can Cope cancer education program. J Health Care Poor Underserved 22(3):912–24CrossRefPubMed Dignan M, Mary E, Polly K, Lori A, Pollack LA, Maria P, Judith Lee S, Heather P-P, Peter H, Christopher W, Sandral H (2011) Recruitment of low income, predominantly minority cancer survivors to a randomized trial of the I Can Cope cancer education program. J Health Care Poor Underserved 22(3):912–24CrossRefPubMed
25.
Zurück zum Zitat Germino Barbara B, Mishel MH, Rumay Alexander G, Coretta J, Diane B, Carol B, Vines AI, Melissa G, Long DG (2011) Engaging African American breast cancer survivors in an intervention trial: culture, responsiveness and community. J Cancer Survivorship 5(1):82–91CrossRef Germino Barbara B, Mishel MH, Rumay Alexander G, Coretta J, Diane B, Carol B, Vines AI, Melissa G, Long DG (2011) Engaging African American breast cancer survivors in an intervention trial: culture, responsiveness and community. J Cancer Survivorship 5(1):82–91CrossRef
26.
Zurück zum Zitat Georgia Robins S, Crystal Y, Lisa M, Kathi G, Linda W, Eric R, Leslie B, Newman VA, Cindy T (2006) Health parties for African American study recruitment. J Cancer Educ 21(2):71–76CrossRef Georgia Robins S, Crystal Y, Lisa M, Kathi G, Linda W, Eric R, Leslie B, Newman VA, Cindy T (2006) Health parties for African American study recruitment. J Cancer Educ 21(2):71–76CrossRef
Metadaten
Titel
Evaluating a Community-Partnered Cancer Clinical Trials Pilot Intervention with African American Communities
verfasst von
Melissa A. Green
Margo Michaels
Natasha Blakeney
Adebowale A. Odulana
Malika Roman Isler
Alan Richmond
Debra G. Long
William S. Robinson
Yhenneko J. Taylor
Giselle Corbie-Smith
Publikationsdatum
01.03.2015
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 1/2015
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-014-0764-1

Weitere Artikel der Ausgabe 1/2015

Journal of Cancer Education 1/2015 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.